CN104529800B - Preparation method of trans-4-dimethylaminocrotonic acid and its salt - Google Patents

Preparation method of trans-4-dimethylaminocrotonic acid and its salt Download PDF

Info

Publication number
CN104529800B
CN104529800B CN201410740561.5A CN201410740561A CN104529800B CN 104529800 B CN104529800 B CN 104529800B CN 201410740561 A CN201410740561 A CN 201410740561A CN 104529800 B CN104529800 B CN 104529800B
Authority
CN
China
Prior art keywords
compound
trans
reaction
preparation
dimethylaminocrotonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410740561.5A
Other languages
Chinese (zh)
Other versions
CN104529800A (en
Inventor
刘泽燕
周兴国
李春林
韩公超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHONGQING WEIPENG PHARMACEUTICAL Co Ltd
Original Assignee
CHONGQING WEIPENG PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHONGQING WEIPENG PHARMACEUTICAL Co Ltd filed Critical CHONGQING WEIPENG PHARMACEUTICAL Co Ltd
Priority to CN201410740561.5A priority Critical patent/CN104529800B/en
Publication of CN104529800A publication Critical patent/CN104529800A/en
Application granted granted Critical
Publication of CN104529800B publication Critical patent/CN104529800B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a preparation method of trans-4-dimethylaminocrotonic acid and its salt and belongs to the field of organic synthesis. The preparation method comprises the following steps that 1, a compound VI (aniline derivative) and a compound V (diethylphosphonoacetic acid) undergo an aminolysis reaction to produce an intermediate IV, 2, the intermediate IV and a compound III ((dimethylamino)-glyoxyl-diethylacetal) undergo a condensation reaction to produce an intermediate II, and 3, the intermediate II undergoes a hydrolysis reaction to produce a desired compound I. The preparation method are simple and efficient synthesis route, is convenient for operation, is free of use of lower-boiling point dangerous chemical dimethylamine, is economic and environmentally friendly, has a high total yield, realizes good product purity and is suitable for industrial production.

Description

Trans -4- Dimethylaminocrotonic acid and the preparation method of salt
Technical field
The present invention relates to organic synthesis field, particularly to the preparation of a kind of trans -4- Dimethylaminocrotonic acid and salt Method.
Background technology
Trans -4- Dimethylaminocrotonic acid is antineoplastic agent HKI-272 (neratinib) and Afatinib (afatinib) important intermediate.Because trans -4- Dimethylaminocrotonic acid contains α, beta-unsaturated carbonyl structure, as There is addition in the nucleophilic group on michael receptor, with corresponding protease, form covalent bond and biological effect occurs.Instead Formula -4- Dimethylaminocrotonic acid and its salt structural formula are as follows:
The synthetic route of existing trans -4- Dimethylaminocrotonic acid is mainly with .beta.-methylacrylic acid as starting material: from not Same blocking group (methoxyl group or trim,ethylchlorosilane) forms ester with carboxyl, is re-introduced into dimethylamino, deprotection obtains target Compound.
Master thesis as Institutes Of Technology Of Nanjing Liu Shuai: " synthesis of medicine intermediate 4- dimethylamino .beta.-methylacrylic acid with Characterize " (Institutes Of Technology Of Nanjing, 2010), the route mentioned is as follows:
Chinese patent cn 100537518c (" synthesis of 4- amino -2-butylene acyl chlorides and its preparation 3- cyano quinolines In application ", Wyeth, application number: cn200480007723.9) in technology path as follows:
Above route has all used dimethylamine, dimethylamine low boiling point, belongs to dangerous materials, to industrialized production equipment with operation all Have higher requirement, and products obtained therefrom yield and purity all low.
Content of the invention
The technical problem to be solved is to overcome the defect of prior art, devise raw material be easy to get, technique letter Clean, the suitable industrialized production of environmental protection and economy, reaction condition, high income trans -4- Dimethylaminocrotonic acid and salt synthesis New method.
Technical scheme is as follows:
A kind of trans -4- Dimethylaminocrotonic acid and the preparation method of salt, comprise the steps: 1) with compound (anil) and compound (diethyl phosphine ethyl acetoacetic acid) occur aminolysis reaction to obtain intermediate;2) intermediate again with Compound ((dimethylamino)-acetaldehyde-diethyl acetal) is condensed to yield intermediate;3) intermediate hydrolysis and obtain Target compound;Reaction equation is as follows:
Described step 1) in compound with the aminolysis reaction of compound be: with oxolane as solvent, by chemical combination Thing adds in oxolane, and stirring adds compound, finishes in 40~50 DEG C of stirring reactions, reactant liquor is poured in frozen water, Stirring, sucking filtration, gained filter cake obtains intermediate in 40~50 DEG C of drying under reduced pressure to constant weight.Described compound and compound Mol ratio be 1:1~2.
Described step 2) intermediate reacted with compound condensation and is: hydrochloric acid or sulphuric acid are cooled to 0 DEG C, Deca chemical combination Thing, finishes in 40~50 DEG C of hydrolysis, then is cooled to 0 DEG C of standby (as reserve liquid a);Sequentially add intermediate in dehydrated alcohol , lithium chloride, be cooled to 0 DEG C, add Sodium ethylate, stirring, Deca reserve liquid a, this step is reacted with lithium chloride as catalyst, no Water-ethanol, as solvent, makes reaction carry out under alkaline environment.Add ethyl acetate, stirring after completion of the reaction, filter, in filtrate Middle addition water, adds anhydrous sodium sulfate drying in organic layer, filters, is evaporated to dry, obtains intermediate.Described hydrochloric acid with The mol ratio of compound is 1~2:1, or sulphuric acid is 0.5~1:1 with the mol ratio of compound;Described compound: in Mesosome: the mol ratio of lithium chloride is: 1~2:1:0.5~1.
Described step 3) reaction that obtains target compound of intermediate hydrolysis is: take intermediate to add under room temperature To in methanol or ethanol or acetone, instill sodium hydroxide or potassium hydroxide solution, be heated to reflux finishing to reaction, reactant liquor is poured into In frozen water, stirring, sucking filtration, obtain pale solid, as target compound.Described intermediate and sodium hydroxide or hydroxide The mol ratio of potassium is: 1:4~8.
The invention has the beneficial effects as follows: the present invention reacts (wittig-horner reacts) as base with phosphorus ylide and aldehyde ketone Plinth and design, there is the aminolysis reaction of acid with anil and diethyl phosphine ethyl acetoacetic acid, form amido link, then with (dimethyl Amino) condensation of-acetaldehyde-diethyl acetal, deprotection and target compound.This synthetic method route is brief, efficient, operation side Just, it is to avoid the use of low boiling hazardous chemical dimethylamine, environmental protection and economy, gross production rate be high, good product purity, is suitable for industry Metaplasia is produced.
Specific embodiment
Embodiment 1
Reacted according to following route:
1st, the preparation of intermediate
5.00g (0.0255mol) compound (diethyl phosphine ethyl acetoacetic acid) is taken to be added in 50ml oxolane (thf), After stirring 30min, add 3.50g (0.0195mol) compound (p-ethyl benzene), finish in 40 DEG C of stirring reactions. Again reactant liquor is poured in 1.0l frozen water, stir 30min, sucking filtration, gained filter cake obtains intermediate in 45 DEG C of drying under reduced pressure to constant weight (2- (4- (2- (diethoxy phosphoryl) acetylamino) phenyl) ethyl acetate).This step yield is about 73%.
2nd, the preparation of intermediate
Under nitrogen protection, take the hydrochloric acid 10.0ml of 6mol/l, be cooled to 0 DEG C, Deca compound ((dimethylamino Base)-acetaldehyde-diethyl acetal) 9.0ml, finishes in 40 DEG C of hydrolysis, then is cooled to 0 DEG C of standby (as reserve liquid a).
Sequentially add above-mentioned prepared intermediate 10.00g, lithium chloride 0.80g in 100ml dehydrated alcohol, be cooled to 0 DEG C, add Sodium ethylate 4.0g, stir 30min, Deca reserve liquid a, the reserve liquid a of aforementioned preparation is all dripped, drip Bi Ji After continuous reaction 40min, add 250ml ethyl acetate, stir 1.0hr, filter, filtrate adds 125ml water, layering.Having Add anhydrous sodium sulfate drying in machine layer, filter, be evaporated to dry, obtain intermediate, this step yield is about 84%.
3rd, the preparation of target compound
Under room temperature, the above-mentioned prepared intermediate of 5.00g (0.0172mol) is taken to be added in 50.0ml methanol or ethanol, Instill 30%naoh solution 15.0ml, be heated to reflux finishing to reaction, reactant liquor is poured in frozen water, stir 30min, sucking filtration, obtain Pale solid, as target compound, this step yield is about 65%.
Embodiment 2
1st, the preparation of intermediate
10.00g (0.051mol) compound (diethyl phosphine ethyl acetoacetic acid) is taken to be added in 100ml oxolane (thf), After stirring 30min, add 10.3g (0.049mol) compound (p-aminophenyl propyl propionate), finish in 45 DEG C of stirring reactions.Again Reactant liquor is poured in 2.0l frozen water, stirs 30min, sucking filtration, gained filter cake obtains intermediate in 45 DEG C of drying under reduced pressure to constant weight (2- (4- (2- (diethoxy phosphoryl) acetylamino) phenyl) ethyl acetate).This step yield is about 70%.
2nd, the preparation of intermediate
Under nitrogen protection, take the sulphuric acid 10.0ml of 6mol/l, be cooled to 0 DEG C, Deca compound ((dimethylamino Base)-acetaldehyde-diethyl acetal) 18.0ml, finishes in 45 DEG C of hydrolysis, then is cooled to 0 DEG C of standby (as reserve liquid a).
Sequentially add above-mentioned prepared intermediate 20.00g, lithium chloride 1.60g in 200ml dehydrated alcohol, be cooled to 0 DEG C, add Sodium ethylate 8.0g, stir 30min, Deca reserve liquid a, the reserve liquid a of aforementioned preparation is all dripped, drip Bi Ji After continuous reaction 50min, add 500ml ethyl acetate, stir 1.0hr, filter, filtrate adds 250ml water, layering.Having Add anhydrous sodium sulfate drying in machine layer, filter, be evaporated to dry, obtain intermediate, this step yield is about 81%.
3rd, the preparation of target compound
Under room temperature, take the above-mentioned prepared intermediate of 10.00g (0.0344mol) to be added in 100.0ml acetone, instill 30%koh solution 30.0ml, is heated to reflux finishing to reaction, reactant liquor is poured in frozen water, stir 30min, sucking filtration, obtain canescence Solid, as target compound, this step yield is about 64%.

Claims (7)

1. the preparation method of a kind of trans -4- Dimethylaminocrotonic acid and salt is it is characterised in that comprise the steps: 1) with Anil and compound occur aminolysis reaction to obtain intermediate;2) intermediate is obtained with compound condensation again Intermediate;3) intermediate hydrolysis and target compound;Reaction equation is as follows:
Described anil is p-ethyl benzene or p-aminophenyl propyl propionate.
2. trans -4- Dimethylaminocrotonic acid according to claim 1 and salt preparation method it is characterised in that: institute Stating compound and the aminolysis reaction of compound in step 1) is: compound is added in oxolane, stirring, and additionization Compound, finishes in 40~50 DEG C of stirring reactions, reactant liquor is poured in frozen water, stirring, sucking filtration, and gained filter cake subtracts in 40~50 DEG C Press dry dry to constant weight, obtain intermediate.
3. trans -4- Dimethylaminocrotonic acid according to claim 1 and salt preparation method it is characterised in that: institute State step 2) intermediate reacted with compound condensation and is: hydrochloric acid or sulphuric acid are cooled to 0 DEG C, Deca compound, in 40 ~50 DEG C hydrolysis finish, then be cooled to 0 DEG C standby, obtain reserve liquid a;Intermediate, chlorination is sequentially added in dehydrated alcohol Lithium, is cooled to 0 DEG C, adds Sodium ethylate, stirring, Deca reserve liquid a, adds ethyl acetate, stirring after completion of the reaction, filter, Add water in filtrate, in organic layer, add anhydrous sodium sulfate drying, filter, be evaporated to dry, obtain intermediate.
4. trans -4- Dimethylaminocrotonic acid according to claim 1 and salt preparation method it is characterised in that: institute State step 3) intermediate hydrolysis and obtain the reaction of target compound and be: under room temperature, take intermediate to be added to methanol or second In alcohol or acetone, instill sodium hydroxide or potassium hydroxide solution, be heated to reflux finishing to reaction, reactant liquor poured in frozen water, stirs Mix, sucking filtration, obtain pale solid, as target compound.
5. trans -4- Dimethylaminocrotonic acid according to claim 1 and 2 and salt preparation method it is characterised in that: Compound described in step 1) is 1:1~2 with the mol ratio of compound.
6. trans -4- the Dimethylaminocrotonic acid according to claim 1 or 3 and salt preparation method it is characterised in that: Step 2) described in the mol ratio of hydrochloric acid and compound be 1~2:1, or the mol ratio of sulphuric acid and compound be 0.5~ 1:1;Described compound: intermediate: the mol ratio of lithium chloride is 1~2:1:0.5~1.
7. trans -4- the Dimethylaminocrotonic acid according to claim 1 or 4 and salt preparation method it is characterised in that: Intermediate described in step 3) is 1:4~8 with the mol ratio of sodium hydroxide or potassium hydroxide.
CN201410740561.5A 2014-12-08 2014-12-08 Preparation method of trans-4-dimethylaminocrotonic acid and its salt Active CN104529800B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410740561.5A CN104529800B (en) 2014-12-08 2014-12-08 Preparation method of trans-4-dimethylaminocrotonic acid and its salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410740561.5A CN104529800B (en) 2014-12-08 2014-12-08 Preparation method of trans-4-dimethylaminocrotonic acid and its salt

Publications (2)

Publication Number Publication Date
CN104529800A CN104529800A (en) 2015-04-22
CN104529800B true CN104529800B (en) 2017-01-25

Family

ID=52845485

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410740561.5A Active CN104529800B (en) 2014-12-08 2014-12-08 Preparation method of trans-4-dimethylaminocrotonic acid and its salt

Country Status (1)

Country Link
CN (1) CN104529800B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108623490A (en) * 2018-06-22 2018-10-09 苏州市贝克生物科技有限公司 The synthetic method of (2Z) -4- (dimethylamino) -2- butenoate hydrochlorates

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009033581A1 (en) * 2007-09-14 2009-03-19 Bayer Schering Pharma Aktiengesellschaft Substituted tricyclic compounds and methods of use thereof
WO2011099764A3 (en) * 2010-02-09 2012-01-05 Hanmi Holdings Co., Ltd. Novel pyrimidine derivative for inhibiting the growth of cancer cells
CN102625797A (en) * 2009-06-25 2012-08-01 迈德药物研发技术有限公司 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10349113A1 (en) * 2003-10-17 2005-05-12 Boehringer Ingelheim Pharma Process for the preparation of aminocrotonyl compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009033581A1 (en) * 2007-09-14 2009-03-19 Bayer Schering Pharma Aktiengesellschaft Substituted tricyclic compounds and methods of use thereof
CN102625797A (en) * 2009-06-25 2012-08-01 迈德药物研发技术有限公司 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
WO2011099764A3 (en) * 2010-02-09 2012-01-05 Hanmi Holdings Co., Ltd. Novel pyrimidine derivative for inhibiting the growth of cancer cells

Also Published As

Publication number Publication date
CN104529800A (en) 2015-04-22

Similar Documents

Publication Publication Date Title
CN103755688B (en) A kind of Ah method is for the preparation method of Buddhist nun's compound
CN102584893B (en) Preparation method for glufosinate
Lu et al. A new chiral diphosphine ligand and its asymmetric induction in catalytic hydroformylation of olefins
CN104529800B (en) Preparation method of trans-4-dimethylaminocrotonic acid and its salt
CN102010447A (en) Preparation method and application of ruthenium and rhodium transition metal complex functional ionic liquid
CN103664769A (en) Synthesis method of dipyridyl derivative or analogue
CN102190683B (en) A kind of phosphorous anion ionic liquid and preparation method thereof
CN101885740B (en) New preparation method of herbicide glyphosate
CN104689849A (en) Phosphamide-(di) secondary amine dual-functional catalyst and synthesis method thereof
CN106238098B (en) A kind of preparation method and its catalyst for preparing of 1,2,4,5- tetra- substituted ramification of imidazole
CN103936683B (en) A kind of 4-amino-5-replaces-1,2,4-triazole-3-thioketone Schiff and preparation method thereof
CN105348101A (en) Preparation method of methyl p-chlorocinnamate
CN110526806A (en) A kind of method that solid acid catalysis phenylacetylene prepares acetophenone compounds
CN103497126B (en) A kind of synthetic method of tamsulosin hydrochloride
CN105601472B (en) The preparation method of new 5 [4 (1 carboxyl naphthyl)] M-phthalic acid
CN109988107A (en) The rich preparation method for Buddhist nun of card
CN109665970A (en) A kind of preparation method of D-Val
CN110684043B (en) C-N axis chiral arylamine compound and preparation method thereof
CN102964225A (en) Preparation method of 2, 3-dichloroanisole
CN101585762B (en) Method for synthesizing 2-(4-cyclopropoxycarbonylphenyl)-2-methylpropanoic acid
CN102316862A (en) The method for preparing S1P receptor stimulating agent or antagonist
CN108727179B (en) Synthetic method of alpha-allyl substituted alpha, beta-unsaturated ketone, ester or nitrile compound
CN103804187B (en) Synthesis method of diethylstilbestrol compound pigeon pea ketonic acid A
CN102060734A (en) Method for preparing N-(4-ethyoxylcarbonylphenyl)-N'-methyl-N'-phenyl carbonamidine
CN101891685A (en) Alkyl imidazole-L-proline salt chiral ionic liquid and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant